North East and North Cumbria
ICS Formulary
ICS Formulary
4 Central nervous system
04-09-01 Dopamine receptor agonists
| Apomorphine |
|
Formulary
|
|
 County Durham Shared Care Guidelines: Apomorphine MHRA Drug Safety Update (April 2016): Apomorphine with domperidone: minimising risk of cardiac side effects North of Tyne, Gateshead and North Cumbria - Apomorphine - Shared Care Guidance South Tyneside & Sunderland APC Shared Care Guideline - Apomorphine injection or infusion for Parkinson’s disease Tees Valley Shared Care Guidelines: Apomorphine |
|
Unlicensed
Links
- County Durham Shared Care Guidelines: Apomorphine
- MHRA Drug Safety Alert (Feb 2015): Drugs and driving: blood concentration limits set for certain drugs
- MHRA Drug Safety Update (April 2016): Apomorphine with domperidone: minimising risk of cardiac side effects
- NENC Palliative and End of Life Care Symptom Control Guidelines
- NICE NG42: Motor neurone disease: assessment and management
- NICE NG62: Cerebral palsy in under 25s: assessment and management
- NICE NG71: Parkinson’s disease in adults
- NICE TA934: Foslevodopa–foscarbidopa for treating advanced Parkinson’s with motor symptoms
- North of Tyne, Gateshead and North Cumbria - Apomorphine - Shared Care Guidance
- South Tyneside & Sunderland APC Shared Care Guideline - Apomorphine injection or infusion for Parkinson’s disease
- Tees Valley Shared Care Guidelines: Apomorphine
- TEWV - Medicines Optimisation – Interactive Guide
- TEWV Guidelines
- TEWV Safe Transfer of Prescribing Guidance